학술논문
Does cystic fibrosis constitute an advantage in COVID-19 infection?
Document Type
Report
Source
Italian Journal of Pediatrics. October 6, 2020, Vol. 46 Issue 1
Subject
Language
English
Abstract
The Veneto region is one of the most affected Italian regions by COVID-19. Chronic lung diseases, such as chronic obstructive pulmonary disease (COPD), may constitute a risk factor in COVID-19. Moreover, respiratory viruses were generally associated with severe pulmonary impairment in cystic fibrosis (CF). We would have therefore expected numerous cases of severe COVID-19 among the CF population. Surprisingly, we found that CF patients were significantly protected against infection by SARS-CoV-2. We discussed this aspect formulating some reasonable theories. Keywords: Cystic fibrosis, SARS-CoV-2, Covid-19, Azythromycin, DNase
Author(s): Valentino Bezzerri[sup.1] , Francesca Lucca[sup.1] , Sonia Volpi[sup.1] and Marco Cipolli[sup.1] Introduction The comorbidities of obesity, hypertension, diabetes, heart failure, and chronic lung disease have been associated with poor [...]
Author(s): Valentino Bezzerri[sup.1] , Francesca Lucca[sup.1] , Sonia Volpi[sup.1] and Marco Cipolli[sup.1] Introduction The comorbidities of obesity, hypertension, diabetes, heart failure, and chronic lung disease have been associated with poor [...]